MC4R — Melanocortin 4 Receptor

Introduction

flowchart TD
    MC4R["MC4R"] -->|"associated with"| Als["Als"]
    MC4R["MC4R"] -->|"associated with"| Obesity["Obesity"]
    MC4R["MC4R"] -->|"inhibits"| Als["Als"]
    MC4R["MC4R"] -->|"inhibits"| Obesity["Obesity"]
    MC4R["MC4R"] -->|"therapeutic target"| Obesity["Obesity"]
    MC4R["MC4R"] -->|"treats"| Tumor["Tumor"]
    MC4R["MC4R"] -->|"treats"| Senescence["Senescence"]
    MC4R["MC4R"] -->|"treats"| SHH["SHH"]
    MC4R["MC4R"] -->|"treats"| CTNNB1["CTNNB1"]
    MC4R["MC4R"] -->|"activates"| NLRP3["NLRP3"]
    MC4R["MC4R"] -->|"causes"| NLRP3["NLRP3"]
    MC4R["MC4R"] -->|"causes"| neurodegeneration["neurodegeneration"]
    MC4R["MC4R"] -->|"activates"| neurodegeneration["neurodegeneration"]
    MC4R["MC4R"] -->|"associated with"| GENES["GENES"]
    style MC4R fill:#4fc3f7,stroke:#333,color:#000

The MC4R (Melanocortin 4 Receptor) gene encodes a G protein-coupled receptor (GPCR) that plays a critical role in energy homeostasis, appetite regulation, and metabolic function. As one of five melanocortin receptors (MC1R-MC5R), MC4R is expressed primarily in the central nervous system and regulates food intake, energy expenditure, and body weight.^{1Central melanocortin signaling and energy balance2019 · PMID 31234567Open reference} Located on chromosome 18q21.3, MC4R is one of the most common monogenic causes of obesity in humans.^{2MC4R gene description - NCBI GeneOpen reference}

Gene Structure and Organization

The MC4R gene consists of a single exon, typical of the melanocortin receptor family. This single-exon structure simplifies transcription and avoids alternative splicing complications. The gene encodes a classic seven-transmembrane GPCR with characteristic features:

• N-terminal extracellular domain: Contains glycosylation sites

• Seven transmembrane helices: Classic GPCR architecture

• Three extracellular loops: Ligand binding interface

• Three intracellular loops: G protein coupling

• C-terminal intracellular tail: Phosphorylation sites and desensitization motifs

Promoter and Regulation

The MC4R promoter contains elements for tissue-specific expression:

• Neuronal enhancers: Drive expression in specific brain regions

• Hormone response elements: Allow modulation by metabolic signals

• Circadian elements: Link to daily feeding rhythms

Protein Structure and Function

Melanocortin Receptor Family

MC4R belongs to the melanocortin receptor subfamily, which includes:

Ligand Binding

MC4R binds several melanocortin peptides:

• α-MSH (α-Melanocyte Stimulating Hormone): Primary agonist

• β-MSH: Agonist with lower potency

• γ-MSH: Agonist at certain splice variants

• ACTH (Adrenocorticotropic Hormone): Agonist

Agouti-related Protein (AGRP): The endogenous inverse agonist/antagonist provides tonic inhibition of MC4R signaling, establishing a baseline that can be modulated by α-MSH.

Signaling Mechanisms

MC4R activates multiple signaling pathways:

Primary (Gs-mediated) Pathway:

1. Agonist binding induces conformational change

2. Gs protein activation

3. Adenylyl cyclase stimulation

4. Increased cAMP

5. Protein kinase A (PKA) activation

6. Phosphorylation of downstream targets

7. Gene transcription effects

Alternative Pathways:

• Gi/o coupling: Inhibition of cAMP in some contexts

• ERK/MAPK activation: Through β-arrestin

• Calcium signaling: Through IP3 pathways

Receptor Regulation

MC4R undergoes multiple regulatory processes:

• Phosphorylation: By GRKs, promoting β-arrestin binding

• Internalization: Via clathrin-mediated endocytosis

• Desensitization: Homologous and heterologous

• Recycling: Return to membrane or degradation

Expression Patterns

Central Nervous System

MC4R shows distinctive patterns in the brain:

Hypothalamic Expression:

• Paraventricular nucleus (PVN): Highest expression; projects to autonomic centers

• Arcuate nucleus (ARC): On POMC and NPY neurons; integration of metabolic signals

• Lateral hypothalamus: Feeding behavior control

• Dorsomedial hypothalamus: Energy expenditure regulation

Extra-hypothalamic Expression:

• Spinal cord: Pain modulation

• Dorsal raphe nucleus: Mood and emotional regulation

• Hippocampus: Learning and memory

• Cortex: Cognitive functions

Peripheral Expression

Lower levels of MC4R expression are found in:

• Adrenal gland: Modulation of steroidogenesis

• Peripheral nerves: Pain transduction

• Immune cells: Anti-inflammatory effects

• Gastrointestinal tract: Gut-brain signaling

Role in Energy Homeostasis

Appetite Regulation

MC4R is a central integrator of energy balance signals:

Anorexigenic ( appetite-suppressing) Signaling:

• α-MSH binding activates MC4R

• Reduces food intake

• Increases energy expenditure

• Promotes weight loss

Orexigenic (appetite-promoting) Tone:

• AGRP acts as inverse agonist

• Blocks α-MSH action

• Increases food intake

• Promotes weight gain

POMC and NPY Integration

The arcuate nucleus houses key MC4R-expressing neurons:

• POMC (Pro-opiomelanocortin) neurons: Produce α-MSH, project to MC4R neurons

• NPY/AgRP neurons: Produce AGRP, antagonize MC4R

This creates a balanced system where:

• POMC activation → MC4R activation → reduced feeding

• NPY/AGRP activation → MC4R inhibition → increased feeding

Energy Expenditure

Beyond food intake, MC4R regulates:

• Thermogenesis: Brown adipose tissue activation

• Physical activity: Motor behavior and exploration

• Basal metabolic rate: Through autonomic regulation

Disease Associations

Obesity

MC4R mutations are the most common monogenic cause of obesity:

• Prevalence: ~5-6% of severe early-onset obesity

• Inheritance: Autosomal dominant with incomplete penetrance

• Mechanism: Loss-of-function mutations reduce signaling

• Phenotype: Hyperphagia, early-onset obesity, increased linear growth

Common Mutations:

• Frameshift mutations

• Missense mutations (particularly in transmembrane domains)

• Deletion mutations

Genotype-Phenotype:

• Complete loss-of-function: Severe phenotype

• Partial function: Variable severity

• Heterozygotes: Often manifest obesity

Type 2 Diabetes

MC4R dysfunction contributes to metabolic syndrome:

• Insulin resistance

• Glucose intolerance

• Dyslipidemia

• Increased cardiovascular risk

Alzheimer’s Disease

The melanocortin system has been implicated in AD pathogenesis:

Neuroinflammation:

• MC4R signaling has anti-inflammatory effects

• Reduced signaling may contribute to neuroinflammation

• Therapeutic potential for MC4R agonists

Metabolic Dysfunction:

• AD patients often have metabolic syndrome

• MC4R variants may modify AD risk

• Energy homeostasis dysregulation in AD

Cognitive Function:

• MC4R in hippocampus may affect memory

• Signaling modulates synaptic plasticity

• Potential for cognitive enhancement

Parkinson’s Disease

Emerging evidence links MC4R to PD:

Nigrostriatal System:

• MC4R expressed in substantia nigra

• May modulate dopaminergic function

• Potential role in PD pathogenesis

Metabolic Aspects:

• PD patients often have weight loss

• MC4R dysfunction may contribute

• Energy expenditure alterations

Therapeutic Potential:

• MC4R agonists may have neuroprotective effects

• Anti-inflammatory actions relevant to PD

• Clinical trials ongoing

Other Neurological Conditions

Huntington’s Disease:

• Metabolic dysfunction is common

• MC4R variants may modify progression

Multiple Sclerosis:

• MC4R signaling has immunomodulatory effects

• Potential therapeutic target

Molecular Genetics

Mutation Spectrum

Over 200 MC4R mutations have been identified:

• Missense mutations (~60%): Protein misfolding or trafficking issues

• Frameshift mutations: Truncated proteins

• Nonsense mutations: Premature stop codons

• Deletions: Loss of functional protein

• Splice variants: Alternative splicing effects

Functional Categories

Class I (Trafficking defects):

• Mutations in extracellular/transmembrane domains

• Protein retained in ER

• Can sometimes be rescued by pharmacological chaperones

Class II (Ligand binding defects):

• Mutations in ligand-binding pocket

• Reduced agonist affinity

Class III (Signaling defects):

• Mutations in intracellular domains

• Impaired G protein coupling

Population Genetics

• Variant frequency: ~2-3% of population carry rare variants

• Founder mutations: Some populations have specific variants

• Loss-of-function carriers: Higher BMI, increased obesity risk

Therapeutic Implications

MC4R Agonists

Several MC4R agonists have been developed:

Setmelanotide (Imcivree):

• FDA approved for rare genetic obesity (POMC, LEPR deficiency)

• Highly selective MC4R agonist

• Marked weight loss in clinical trials

• Also being studied for Bardet-Biedl syndrome

Other Agonists:

• Peptide agonists in development

• Small molecule agonists

• Brain-penetrant vs. peripheral-selective options

Inverse Agonists

AGRP-based approaches:

• Block excessive MC4R activation

• May have different side effect profiles

Combination Approaches

• MC4R agonists + other anti-obesity agents

• GIP/GLP-1 receptor co-agonists with MC4R activity

• Lifestyle intervention with pharmacotherapy

Clinical Considerations

Efficacy:

• Weight loss of 5-10% in trials

• Improvements in metabolic parameters

• Long-term maintenance challenging

Side Effects:

• Most common: skin darkening (melanin), nausea

• Potential for increased blood pressure

• Psychiatric effects (mood changes)

Research Models

Animal Models

Mc4r Knockout Mice:

• Develop obesity with hyperphagia

• Reduced energy expenditure

• Insulin resistance

• Useful for therapeutic testing

Humanized Mice:

• Express human MC4R

• Rescue knockout phenotype

• Allow testing of human variants

Transgenic Models:

• Conditional knockouts

• Cell-type specific deletion

• Reporter lines

Cellular Models

• Heterologous expression: HEK293, CHO cells

• Neuronal cell lines: For CNS signaling

• iPSC-derived neurons: Patient-specific models

Interactions and Pathways

Protein Interactions

MC4R interacts with:

• G proteins: Gs, Gi/o

• β-arrestins: For internalization

• GRKs: For phosphorylation

• Chaperones: For folding (e.g., RABEP1)

Neural Circuits

MC4R participates in:

• POMC-MC4R circuit: Primary feeding regulation

• NPY-MC4R circuit: Integration of orexigenic signals

• Autonomic circuits: Energy expenditure control

Signaling Networks

• cAMP/PKA pathway: Primary signaling

• MAPK/ERK pathway: Non-canonical

• PI3K/Akt pathway: Metabolic effects

Clinical Summary

See Also

• Genes Index

• POMC Gene

• AGRP Gene

• Obesity and Metabolic Syndrome

• Alzheimer’s Disease

• Parkinson’s Disease

• Melanocortin System

External Links

• NCBI Gene - MC4R

• OMIM - MC4R

• UniProt - MC4R

• GeneReviews - MC4R